Park Y.E.,Cheon J.H. .2017 ."Updated treatment strategies for intestinal Behçet's disease.". Korean Journal of Internal Medicine, 377(2018) : 1-19.
Kirino Y.,Nakajima H. . ."Clinical and genetic aspects of Behçet's disease in Japan.". Internal Medicine, 18(2019) : 1199-1207.
Tong B. .2019 ."Immunopathogenesis of Behçet's disease." Frontiers in Immunology. , 00665 : 665.
Scherrer M.A.R. . ."Behçet's disease: review with emphasis on dermatological aspects.". Anais Brasileiros de Dermatologia, 92(2017) : 20177359-464.
Sfikakis P.P. . ."Anti-TNF therapy in the management of Behçet's disease-review and basis for recommendations.". Rheumatology (Oxford), 46(2007) : 736-741.
Kump L.I. . ."Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute.". Canadian Journal of Ophthalmology, 43(2008) : 080-472.
'Angelo D,S. D .2014 .-factors-for -the- response- to-infliximabtherapy-in-patients-with-behcets-disease/.. " ACR/ARHP Annual Meeting, : .
Onal S. .2011 ."Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis.". Archives of Ophthalmology, 3(2011) : 288-294.
Kavandi H. .2016 ."Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behçet's disease. " Clinical Rheumatology, 35(11) : 2765-2769.
Taylor S.R. .2011 ."Behçet disease: visual prognosis and factors influencing the development of visual loss.". American Journal of Ophthalmology, 05(2011) : 1059-1066.
Celiker H. .2018 ."Factors affecting relapse and remission in Behçet's uveitis treated with interferon alpha-2a.". Journal of Ocular Pharmacology and Therapeutics, 0059(2019) : 58-65.
.2006 .International Team for the Revision of the International Criteria for Behçet's Disease. "Evaluation of the International Criteria for Behçet's disease (ICBD)." Clinical and Experimental Rheumatology. , 42(suppl) : S13.
Zouboulis C.C. .2003 ."Onset signs, clinical course, prognosis, treatment and outcome of adult patients with AdamantiadesBehçet's disease in Greece." Clinical and Experimental Rheumatology. 4 suppl. 30, 21 : 2513-S26.
El-Garf A. .2018 ."Behçet's disease patterns and subsets in a cohort of Egyptian patients. " Egyptian Rheumatology, 05(2019) : 135-138.
Menyawi El,M.M. El .2009 ."Clinical features of Behçet's disease in Egypt.". Rheumatology International, 29 : 641-646.
El-Najjar A.R. .2014 ."Clinical characteristics and disease activity of Behçet's disease patients in Zagazig. Egypt." Egyptian Rheumatology, 11 : 191-196.
Arevalo J.F. .2014 .". American Journal of Ophthalmology, 10(2015) : 177-184.
. .Behçet's disease. , : .
Barnes C.G. . ."Treatment of Behçet's syndrome.". Rheumatology (Oxford), 45(2006) : 245-247.
Davatchi F. .2010 ."Behçet's disease: from east to west.". Clinical Rheumatology, 29 : 823-833.
Shakibi M.R. .2004 .". Journal of Medical Sciences, 120(2004) : 120-123.
Y.K. ,atertiary- ,- ,- ,- ,- ,- ,- . .sg/behcets-disease-experience-in-. , 33(2004) : 510-514.
Chin A.B.,Kumar A.S. . ."Behçet colitis." Clinical Colon and Rectal Surgery. , 28(2015) : 99-102.
Lopalco G.,Article ID .2017 ."Update on the medical management of gastrointestinal Behçet's disease.". Mediators of Inflammation, : .
Oner-Alibaz F. .2015 ."Behçet disease with vascular involvement.". Medicine (Baltimore), 94(6) : .
Saleh Z. . .. and T. Arayssi. "Update on the therapy of Behçet disease." Therapeutic Advances in Chronic Disease, 5(2014) : 112-134.